Immunodeficiency following hereditary defective response to Epstein-Barr virus

D3_IMMUDEFPOSTEBV

No definition available.

Endpoint definition

FinnGen phenotype data

392423 individuals

diagram downward connector

Apply sex-specific rule None

392423

diagram downward connector

Check conditions None

392423

diagram downward connector
diagram bullet

Check pre-conditions, main-only, mode, registry filters

Hospital Discharge: ICD-10 D82.3
Cause of death: ICD-10 D82.3

2 out of 7 registries used, show all original rules.

-

diagram downward connector

Check minimum number of events None

-

diagram downward connector

Include endpoints None

-

diagram downward connector
diagram bullet diagram downward connector

Remove individuals based on genotype QC

-

diagram downward connector
D3_IMMUDEFPOSTEBV

Control definitions

Control exclude D3_IMMUNEMECHANISM

Extra metadata

Level in the ICD hierarchy 4
First used in FinnGen datafreeze DF2
Parent code in ICD-10 D82
Name in latin Deficientia immunalis cum responso defectivo contra agentem viralem Epstein-Barr

Similar endpoints

List of similar endpoints to Immunodeficiency following hereditary defective response to Epstein-Barr virus based on the number of shared cases.

Venn diagram with an highlighted set fully inside another set Broader endpoints:

None

Venn diagram with a set fully inside an highlighted set Narrower endpoints:

None

Show all endpoint correlations

Summary Statistics

Key figures

All Female Male
Number of individuals - - -
Unadjusted prevalence (%) - - -
Mean age at first event (years) - - -

Mortality

Follow-up Absolute risk HR [95% CI] p N
1998–2019 - - - -
15 years - - - -
5 years - - - -
1 year - - - -

Age distribution of first events

Year distribution of first events

Cumulative Incidence

Correlations

Index endpoint: D3_IMMUDEFPOSTEBV – Immunodeficiency following hereditary defective response to Epstein-Barr virus
GWS hits:

Survival analyses between endpoints

Not a core endpoint, no data to show.

Drugs most likely to be purchased after Immunodeficiency following hereditary defective response to Epstein-Barr virus

Endpoint not on priority list, no data to show.